Question 1

What is the catalog number for C8orf70 (Family with Sequence Similarity 164, Member A, C8orf70, CGI-62)?

Accepted Answer

The catalog number for C8orf70 (Family with Sequence Similarity 164, Member A, C8orf70, CGI-62) is 244089.

Question 2

What sizes are available for C8orf70 (Family with Sequence Similarity 164, Member A, C8orf70, CGI-62)?

Accepted Answer

C8orf70 (Family with Sequence Similarity 164, Member A, C8orf70, CGI-62) is available in the following size(s): 50 µL.

Question 3

Is C8orf70 (Family with Sequence Similarity 164, Member A, C8orf70, CGI-62) in stock?

Accepted Answer

C8orf70 (Family with Sequence Similarity 164, Member A, C8orf70, CGI-62) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 5

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Question 6

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

C8orf70 (Family with Sequence Similarity 164, Member A, C8orf70, CGI-62)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

VLDL-Receptor (Very Low Density Lipoprotein Receptor) (VLDLR/2896R), CF405S conjugate, 0.1mg/mL

Filaggrin (Keratinocyte Differentiation Marker) (rFLG/1561), CF594 conjugate, 0.1mg/mL

Involucrin (SY5), 1mg/mL

CD45RB (B-Cell Marker) (PTPRC/2877R), CF488A conjugate, 0.1mg/mL

CD56 / NCAM (123C3.D5), CF568 conjugate, 0.1mg/mL

TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer) (TIGIT/3017), CF640R conjugate, 0.1mg/mL